2. SCIENTIFIC KNOWLEDGE BASE  ENTRY AND MULTIPLICATION OF ORGANISM RESULTS IN DISEASE  COLONIZATION OCCURS WHEN A MICROORGANISM INVADES THE HOST BUT DOES NOT CAUSE INFECTION (INJURY TO CELLS)  COMMUNICABLE DISEASE

3. CHAIN OF INFECTION  INFECTIOUS AGENT OR PATHOGEN  ENDOTOXINS  EXOTOXINS  SEE TABLE 29-1 PAGE 508 IGNATAVICIUS  SEE TABLE 33-1 PAGE 775 POTTER & PERRY  RESERVOIR OR SOURCE OF PATHOGEN GROWTH  CARRIERS

4. CHAIN OF INFECTION  PORTAL OF EXIT  MODE OF TRANSMISSION  DIRECT OR INDIRECT  DROPLET  AIR  VECTOR  VEHICLES

5. CHAIN OF INFECTION  PORTAL OF ENTRY (MAY BE THE SAME AS PORTAL OF EXIT)  SUSCEPTIBLE HOST

6. SUSCEPTIBLE HOST FACTORS

7. INFECTIOUS PROCESS  INCUBATION PERIOD  PRODROMAL STAGE  ILLNESS STAGE  CONVALESCENCE

8. INFECTIOUS ORGANISMS  PRIONS  VIRUSES  BACTERIA  FUNGI  PROTOZOA  HELMINTHS  MYCOPLASMS  RICKETTSIAE

9.  PORTAL OF ENTRY  RESPIRATORY  GI  GU  SKIN  MUCOS MEMBRANE  BLOOD STREAM

10. DEFENSES AGAINST INFECTION NON-SPECIFIC DEFENSES  NORMAL FLORA  BODY TISSUE  ORGAN SYSTEM DEFENSE RESPIRATORY GI GU

11. INFECTIOUS PROCESS  LOCALIZED  SYSTEMIC  PATHOGENICITY

12. DEFENSES AGAINST INFECTION NON-SPECIFIC DEFENSE  INFLAMMATION  PHAGOCYTOSIS  VASCULAR AND CELLULAR RESPONSE  EDEMA  PHAGOCYTOSIS  LEUKOCYTOSIS  INFLAMMATORY EXUDATE  SEROUS  SANGUINOUS  PURULENT

13. SPECIFIC DEFENSES AGAINST INFECTION  CELL- MEDIATED IMMUNITY  ANTIBODY-MEDIATED IMMUNITY

14. HEALTH CARE ASSOCIATED INFECTION (NOSOCOMIAL)  INFECTIONS ACQUIRED BY THE PATIENT IN THE HEALTH CARE SETTING WHICH WERE NOT PRESENT AT ADMISSION EXOGENOUS ENDOGENOUS IATROGENIC

15. METHODS OF INFECTION CONTROL  HAND HYGIENE  GLOVES  CDC GUIDELINES FOR DISINFECTION AND STERILIZATION STANDARD, AIRBORNE, DROPLET, CONTACT  STANDARD PRECAUTIONS FOR ALL MODES OF TRANSMISSION

16. ASSESSMENT OF PATIENT WITH SUSPECTED INFECTION  REVIEW OF PAST DISEASES  TRAVEL HISTORY  IMMUNIZATION HISTORY  STATUS OF DEFENSE MECHANISM  PATIENT SUSCEPTIBILITY  CLINICAL APPEARANCE AND MANIFESTATIONS

17.  LAB TESTING CULTURE AND ANTIBIOTIC SENSITIVITY TESTING CBC ERYTHROCYTE SEDIMENTARY RATE WBC WITH DIFFERENTIAL IRON LEVELS

18. LAB TESTING SEROLOGIC TESTING RADIOGRAPHIC ASSESSMENT

19. NURSING DIAGNOSIS AND PLANNING  NANDA APPROVED DIAGNOSIS  GOALS AND OUTCOMES MEASURABLE REALISTIC  PRIORITIES

20. INTERVENTIONS  MEDICAL AND SURGICAL ASEPSIS  CONTROL/ELIMINATION OF INFECTIOUS AGENTS  CONTROL/ELIMINATION OF: MODES OF TRANSMISSION PORTALS OF ENTRY RESERVOIRS  HAND HYGIENE (HCP, PATIENT, FAMILY)

21. INTERVENTIONS  ISOLATION PRECAUTIONS  HYPERTHERMIA INTERVENTION ELIMINATE UNDERLYING CAUSE FEVER MANAGEMENT  HEALTH TEACHING  ANTIBIOTIC THERAPY  PSYCHOSOCIAL SUPPORT  HEALTH CARE RESOURCES

22. EVALUATION  MEASURE SUCCESS OF INFECTION CONTROL TECHNIQUES  COMPARE PATIENT’S RESPONSE TO ACTUAL OUTCOME  WHAT WILL YOU DO IF GOAL/OUTCOMES NOT ACHIEVED?